Search Results 111-120 of 14816 for Hepatitis C
Glecaprevir and pibrentasvir combination is used to treat chronic hepatitis C virus (HCV) genotypes 1, 2, 3, 4, 5, or 6 infection in patients without cirrhosis ...
The purpose of this study is to evaluate ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) in participants with chronic genotype 1 or 4 hepatitis C ...
Left untreated, hepatitis C can cause serious liver damage, cirrhosis and even death. On the next Mayo Clinic Radio, infectious diseases specialist Dr. Stacey ...
For hepatitis C virus infection: Adults—One tablet once a day, taken for 12 weeks. Each tablet contains sofosbuvir 400 milligrams (mg) and velpatasvir 100 ...
Hepatitis is inflammation in the liver caused by specific viruses. The hepatitis viruses are referred to as types A, B, C, D and E. All types affect the ...
A Mayo Clinic study previously found that livers from donors exposed to hepatitis C could safely be transplanted. Now that research is expanding to other solid ...
hepatitis C, especially for people born between 1945 and 1965. Also on the program, allergy specialist Dr. Rohit Divekar explains why it's important to diagnose ...
Hepatitis C can be cured. All adults should be screened for hepatitis C at least once. If you're concerned about your risk of liver cirrhosis, talk to a health ...
The Hepatobiliary Cancer Lab of Lewis R. Roberts, M.B., Ch.B., Ph.D., at Mayo Clinic targets liver cancer genes and works to prevent hepatitis B and C ...
Cholangiocarcinoma, Primary sclerosing cholangitis, Hepatitis C, Hepatitis B, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.